News: NVISION Laser Eye Centers Introduce Dry Eye Clinics

PRESS RELEASE NEWPORT BEACH, CA, Oct 11, 2010 NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, is introducing its first new service since changing its name last month. "If you're one of 22 million people nationwide who suffer daily from dry eyes, the Dry Eye Clinic at our eight NVISON Laser Eye Centers … [Read more...]

Dry Eye Disease – The Arthritis of the Eye

eye_arthritis

Part of the difficulty in assessing the clinical severity of mild to moderate dry eye disease lies in the myriad of factors that contribute to its progression. During my studies as a biomedical engineer, we were trained to look for the mechanism of the disease, to make salient estimates of the physical and chemical forces that … [Read more...]

In My Practice : Robert L. Davis, O.D., F.A.A.O.

TearLab is an interesting new technology but how do I use the results from the test to improve my patients symptoms? Has it really been validated? Does it really make a difference? At Vision Expo the most common discussions I heard from colleagues; I buy into the science that osmolarity is the best bio-marker for determining DED … [Read more...]

TearLab announces Medicare Reimbursement

tear stock chart

http://www.marketwatch.com/story/tearlab-shares-soar-on-medicare-update-2010-10-08 By Val Brickates Kennedy BOSTON (MarketWatch) -- Shares of diagnostic test developer TearLab Corp.  (TEAR 3.08, +0.35, +12.82%) soared in early action Friday after it announced that its TearLab Osmolarity test … [Read more...]

Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy

Monaco G, Cacioppo V, Consonni D, Troiano P. Ophthalmology Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan - Italy. Abstract Purpose. To determine the effects of 2 artificial tear formulas on the ocular surface in patients with glaucoma using topical preserved beta-blockers (BB) or … [Read more...]